Well cover: Whether retatrutide directly causes hair loss Why shedding sometimes happens during weight loss How to prevent it What science currently says And how to approach treatment safely and responsibly Understanding Retatrutide and How It Works Retatrutide is a next-generation investigational weight-loss therapy that targets three key metabolic pathways: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon receptors Unlike older weight-loss drugs, this triple-action mechanism influences: Appetite regulation Fat metabolism Blood sugar control Energy balance Because of this powerful effect, users may experience significant and relatively rapid weight loss compared to traditional approaches
Jr., Seeley, R
Mass spectrometric analysis of L-carnitine and its esters: Potential biomarkers of disturbances in carnitine homeostasis
The blockbuster success of Novo Nordisks Ozempic/Wegovy and Lillys Mounjaro/Zepbound, all injectables, have put GLP-1/GIP agonists on the map, but will new oral drugs be a game-changer
Davies M, Frch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I, STEP 2 Study Group (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial